Supplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens

September 2022 | Volume 21 | Issue 9 | SF3595563 | Copyright © September 2022


Published online September 2, 2022

Hilary E. Baldwin MDa, Andrew F. Alexis MD MPHb, Anneke Andriessen PhDc, Diane S. Berson MD FAADd, Julie Harper MDe, Edward Lain MD FAADf, Shari Marchbein MDg, Linda Stein Gold MD FAADh

aAcne Treatment & Research Center, Brooklyn, NY
bClinical Dermatology, Weill Cornell Medical College, New York, NY
cRadboud UMC Nijmegen, Andriessen Consultants, Malden, The Netherlands
dWeill Medical College of Cornell University, New York-Presbyterian Hospital, New York, NY
eThe Dermatology and Skin Care Center of Birmingham, Birmingham, AL
fSanova Dermatology, Austin TX; Austin Institute for Clinical Research, Austin, TX
gNYU School of Medicine, New York, NY
hHenry Ford Health System, Detroit, MI

REFERENCES

1. Gallo RL, Granstein RD, Kang S et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018; 78: 148– 55.
2. Tan J, Schöfer H, Araviiskaia E, Audibert F, Kerrouche N, Berg M, The RISE study group Prevalence of rosacea in the general population of Germany and Russia—the RISE study. J Eur Acad Dermatol Venereol. 2016;30:428–434. doi: 10.1111/jdv.13556.
3. Schaller M, Almeida LMC, Bewley A et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea Consensus 2019 panel. Br J Dermatol. 2020; 182:1909-1091.
4. Woo YR, Lim JH, Cho DH, Park HJ. Rosacea: molecular mechanisms and management of a chronic cutaneous inflammatory condition. Int J Mol Sci. 2016; 17(9):1562; doi:10.3390/ijms17091562
5. Alexis AF, Callender VD, Baldwin HE, Desai SR, Rendon MI, Taylor SC. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color. Review and clinical practice experience. J Am Acad Dermatol. 2019;80(6):1722-1729. DOI:https://doi.org/10.1016/j. jaad.2018.08.049
6. Baldwin H, Alexis AF, Andriessen A, Berson DS, Farris P, Harper J, Lain E, Marchbein S, Stein Gold L, Tan J. Evidence of barrier deficiency in rosacea and the importance of integrating OTC skincare products into treatment regimens. J Drugs Dermatol. 2021 April 1;20(4):384-392.
7. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72:749-58. https://doi.org/10.1016/j. jaad.2014.08.028
8. Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol. 2017;26:659-67. https://doi.org/10.1111/exd.13143
Close Menu